Hydroxyurea treatment is associated with lower malaria incidence in children with sickle cell anemia in sub-Saharan Africa.Olupot-Olupot, P. Tomlinson, G. Williams, T. N. Tshilolo, L. Santos, B. Smart, L. R. McElhinney, K. Howard, T. A. Aygun, B. Stuber, S. E. Lane, A. Latham, T. S. Ware, R. E.
Blood, (2023). 141:1402-1410

Subphenotypes of sickle cell disease in Africa.Piel, F. B. Williams, T. N.
Blood, (2017). 130:2157-2158

Combinatorial effects of malaria season, iron deficiency, and inflammation determine plasma hepcidin concentration in African children.Atkinson, S. H. Armitage, A. E. Khandwala, S. Mwangi, T. W. Uyoga, S. Bejon, P. A. Williams, T. N. Prentice, A. M. Drakesmith, H.
Blood, (2014). 123:3221-9

Epistasis between the haptoglobin common variant and alpha+thalassemia influences risk of severe malaria in Kenyan children.Atkinson, S. H. Uyoga, S. M. Nyatichi, E. Macharia, A. W. Nyutu, G. Ndila, C. Kwiatkowski, D. P. Rockett, K. A. Williams, T. N.
Blood, (2014). 123:2008-16

High mortality from Plasmodium falciparum malaria in children living with sickle cell anemia on the coast of Kenya.McAuley, C. F. Webb, C. Makani, J. Macharia, A. Uyoga, S. Opi, D. H. Ndila, C. Ngatia, A. Scott, J. A. Marsh, K. Williams, T. N.
Blood, (2010). 116:1663-8

Malaria in patients with sickle cell anemia: burden, risk factors, and outcome at the outpatient clinic and during hospitalization.Makani, J. Komba, A. N. Cox, S. E. Oruo, J. Mwamtemi, K. Kitundu, J. Magesa, P. Rwezaula, S. Meda, E. Mgaya, J. Pallangyo, K. Okiro, E. Muturi, D. Newton, C. R. Fegan, G. Marsh, K. Williams, T. N.
Blood, (2010). 115:215-20

Both heterozygous and homozygous alpha+ thalassemias protect against severe and fatal Plasmodium falciparum malaria on the coast of Kenya.Williams, T. N. Wambua, S. Uyoga, S. Macharia, A. Mwacharo, J. K. Newton, C. R. Maitland, K.
Blood, (2005). 106:368-71